Development of Medication Reconciliation Model for Chronic Kidney Disease in Our Hospital
ZHAO Rui1, HANG Yong-fu1, LIU Xing-xing2, TAN Xin3, YANG Yang4, CHEN Lin1*, BAO Jian-an1, MIAO Li-yan1
1. Department of Pharmacy The First Affiliated Hospital of Soochow University, Suzhou 215006, China; 2. Department of Pharmacy, Guiyang Maternal and Children Health-Care Hospital, Guiyang 550004, China; 3. Department of Pharmacy, Northern Jiangsu People′s Hospital, Yangzhou 225000, China; 4. Department of Pharmacy, Wuxi No.2 People′s Hospital, Wuxi 214002, China
Abstract：OBJECTIVE To develop the model of medication reconciliation (MR) service provided by clinical pharmacist for chronic kidney disease (CKD). METHODS The definition, working process, development of MR were analyzed and the medication problems we reviewed were classified and intervened according to the newest Pharmaceutical Care Network Europe (PCNE) V9.0 classification scheme which was constructed for drug related problems (DRPs) to analysis and summary. We stated and summarized procedure of MR by several cases based on the realities of our hospital. RESULTS A new closed loop model of outpatient clinic to hospital, then to home was developed, a working process was made according to three settings consist of outpatient clinic, hospital and home. CONCLUSION The procedure of MR of several cases was summarized based on the realities on our hospital.
赵瑞, 杭永付, 刘星星, 谈心, 杨漾, 陈琳, 包健安, 缪丽燕. 我院慢性肾脏病患者药物重整服务模式的建立[J]. 中国药学杂志, 2020, 55(5): 408-412.
ZHAO Rui, HANG Yong-fu, LIU Xing-xing, TAN Xin, YANG Yang, CHEN Lin, BAO Jian-an, MIAO Li-yan. Development of Medication Reconciliation Model for Chronic Kidney Disease in Our Hospital. Chinese Pharmaceutical Journal, 2020, 55(5): 408-412.
ZHANG L X, WANG F, WANG L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet,2012,379(9818):815-822.
[2]
STPETER W L, WAZNY L D, PATEL U D. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management[J]. Curr Opin Nephrol Hypertens,2013,22(6):656-662.
[3]
LE K D, LIANG Y, YANG C Q. Medication reconciliation by clinical pharmacists for patients with chronic kidney disease[J]. Chin J New Drugs(中国新药杂志),2017,26(10):1213-1218.
[4]
LIU Y, CUI X L, LIU L H. Brief analysis of medication reconciliation between domestic and foreign[J]. Chin Pharm J(中国药学杂志),2015,50(24):2099-2112.
[5]
YAO H J, LI P, LIU X Z, et al. Pharmaceutical care practice for admission medication reconciliation in the internal medicine inpatient by clinical pharmacists[J]. J China Pharm(中国药房),2017,28(32):4580-4584.
[6]
Joint Commission on Accreditation of Healthcare Organizations. Using medication reconciliation to prevent errors[J]. Sentinel Event Alert,2006,(35):1-4.
[7]
Institute for healthcare Improvement. Medication reconciliation to prevent adverse drug events[EB/OL]. [2019-12-25]. http://www.ihi.org/topics/adesmedicationreconciliation/Pages/default.aspx.
[8]
LEOTSAKOS A, ZHENG H, CROTEAU R. Standardization in patient safety: the WHO high 5s project[J]. Int J Qual Health Care, 2014,25(2):109-116.
[9]
ALMANASREH E, MOLES R, CHEN T F. The medication reconciliation process and classification of discrepancies: a systematic review[J]. Br J Clin Pharmacol,2016,82(3):645-658.
[10]
SPLAWSKI J, MINGER H. Value of the pharmacist in the medication reconciliation process[J]. P T,2016,41(3):176-178.
[11]
MEKONNEN A B, MCLACHLAN A J, BRIEN J A. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and Meta-analysis[J]. BMJ Open, 2016, 6(2):e010003.
[12]
ASHP statement on the pharmacist′s role in medication reconciliation[J]. Am J Health Syst Pharm,2013,70(5):453-456.
[13]
Pharmaceutical Care Network Europe Association. PCNE Classification for Drug related problems[EB/OL]. [2019-12-25]. https://www.pcne.org/working-groups/2/drug-related-problem-classification.
[14]
WANG H X, ZHU X T, XIE C, et al. Primary medication reconciliation service provided by clinical pharmacist for chronic kidney disease in our hospital[J]. Chin Pharm J(中国药学杂志),2018,53(24):2148-2151.
[15]
ZHU X T, HANG Y F. Clinical pharmacists′ pharmaceutical care and practice in the department of nephrology[J]. Chin J Clin Pharmacol Ther(中国临床药理学与治疗学),2018,23(10):1174-1178.
[16]
WANG H X, HANG Y F. Pharmaceutical services in the department of nephrology: examples and experiences[J]. Cent South Pharm(中南药学),2019,17(4):607-609.
[17]
ZIMMERMAN K M, SALGADO T M, DIXON D L. Medication reconciliation vs medication review[J]. JAMA,2017,318(10):965-966.
2020, Vol. 55 
